Group A | Pre-observation | Post-observation | P value |
Frequency | 11.0 (1.0) | 11.0 (1.0) | 0.200 |
Urgency episodes | 6.5 (1.0) | 7.0 (1.0) | 0.093 |
Nocturia episodes | 2.0 (1.0) | 1.0 (1.0) | 0.231 |
Incontinence episodes | 2.0 (1.0) | 2.0 (2.0) | 0.332 |
Incontinence pads | 5.0 (2.0) | 5.0 (2.0) | 0.231 |
Voided volume (ml) | 121.5 (31.0) | 114.5 (27.0) | 0.001 |
Group B | Pre-treatment | Post-treatment | P value |
Frequency | 11.0 (2.0) | 9.0 (2.0) | < 0.001 |
Urgency episodes | 7.0 (2.0) | 4.0 (2.0) | < 0.001 |
Nocturia | 2.0 (1.0) | 1.0 (1.0) | < 0.001 |
Incontinence episodes | 2.0 (1.0) | 1.0 (1.0) | < 0.001 |
Incontinence pads | 4.0 (2.0) | 2.0 (2.0) | < 0.001 |
Voided volume (ml) | 117.0 (33.0) | 148.0 (26.0) | < 0.001 |